Vitro SAB de CV (VITOF) Stock Statistics & Valuation Metrics

Vitro SAB de CV has a market cap or net worth of $163.29M. The enterprise value is $305.61M.

Vitro SAB de CV has 483,571,400 shares outstanding. The number of shares has decreased by -2.65% in one year.

Vitro SAB de CV’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 0.58%.

The current PE Ratio of Vitro SAB de CV is 0.9. Vitro SAB de CV’s PEG ratio is ―.

In the last 12 months, Vitro SAB de CV had revenue of 300.37M and earned 138.05M in profits. Earnings per share was 0.29.

In the last 12 months, operating cash flow was 729.99M and capital expenditures -110.71M, giving a free cash flow of 619.17M billion.

Vitro SAB de CV pays an annual dividend of ―, resulting in a dividend yield of ―

Vitro SAB de CV upcoming earnings date is Jul 26, 2024, TBA (Confirmed).

Vitro SAB de CV as a current ratio of 1.20, with Debt / Equity ratio of 8.15%

In the past 12 months, Vitro SAB de CV has paid 22.87M in taxes.

Vitro SAB de CV EV to EBITDA ratio is 8.70, with an EV/FCF ratio of 2.07.

Vitro SAB de CV has $10.05M in cash and marketable securities with ― in debt, giving a net cash position of -$63.10M billion.

Gross margin is 39.11%, with operating margin of 2.06%, and net profit margin of 45.96%.

The average price target for Vitro SAB de CV is ―, which is 11.43% higher than the current price. The consensus rating is ―